70518-2046 : Glyxambi Oral Tablet, Film Coated


NDC: 70518-2046
Labeler: Remedyrepack Inc.
Product Type: Human Prescription Drug
Drug Name:  Glyxambi
Dosage Form: Oral Tablet, Film Coated
Application #: NDA206073
Rev. Date: 


Appearance:


Markings: 10;5
Shapes:  Triangle (3 sides)
Colors:  Yellow
Size (mm): 8
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 70518-2046-0: 90 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC (70518‑2046‑0)

Active Ingredients:

  • Empagliflozin
  • Linagliptin

Dosage Strength:

  • 10 mg
  • 5 mg

Pharmaceutical Classes:

  • Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
  • Sodium-Glucose Transporter 2 Inhibitors [MoA]
  • Dipeptidyl Peptidase 4 Inhibitors [MoA]
  • Dipeptidyl Peptidase 4 Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 0597-0164 Glyxambi Oral Tablet, Film Coated by Boehringer Ingelheim Pharmaceuticals, Inc.
  • 0597-0182 Glyxambi Oral Tablet, Film Coated by Boehringer Ingelheim Pharmaceuticals, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 70518-2046 QR Code

< Prev: 70518-2045Next: 70518-2047 >

Related Discussions:

trajenta linagliptin
what is deference between istamet and trajenta and side effects...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.